Target type: biologicalprocess
Any biological process involved in the maintenance of the steady-state number of hematopoietic stem cells within a population of cells. [GOC:dph, PMID:21508411]
Hematopoietic stem cell (HSC) homeostasis is a tightly regulated process that ensures the lifelong production of all blood cell types. This complex process involves a balance of self-renewal, differentiation, and apoptosis, ensuring a constant pool of HSCs while maintaining a healthy blood system.
**Self-renewal:** HSCs have the unique ability to divide asymmetrically, producing one daughter cell that remains an HSC, preserving the stem cell pool, while the other differentiates into a progenitor cell. This process requires precise regulation of signaling pathways, including Wnt, Notch, and Hedgehog pathways.
**Differentiation:** Progenitor cells derived from HSCs undergo a series of differentiation steps to generate various blood cell lineages, including erythrocytes (red blood cells), leukocytes (white blood cells), and platelets. This process involves a cascade of transcription factors and signaling molecules that control cell fate decisions and commitment to specific lineages.
**Apoptosis:** A regulated process of programmed cell death eliminates damaged or redundant HSCs, maintaining the quality and function of the stem cell pool. Apoptosis is triggered by various stimuli, including DNA damage, oxidative stress, and cytokine withdrawal.
**Regulation of HSC Homeostasis:**
* **Microenvironment (niche):** HSCs reside in specific microenvironments within the bone marrow, known as niches. These niches provide essential signals and support for HSC self-renewal and differentiation. Key components of the niche include stromal cells, vascular cells, and extracellular matrix.
* **Cytokines and growth factors:** A variety of cytokines and growth factors regulate HSC behavior, including stem cell factor (SCF), thrombopoietin (TPO), and erythropoietin (EPO). These factors act through specific receptors on HSCs, modulating their proliferation, survival, and differentiation.
* **Transcription factors:** Transcription factors play crucial roles in regulating gene expression and directing HSC fate decisions. Key transcription factors involved in HSC homeostasis include GATA-1, PU.1, and RUNX1.
**Maintaining HSC Homeostasis:**
* **Age-related decline:** HSC function and self-renewal capacity decline with age, leading to a reduced ability to produce blood cells and an increased susceptibility to blood disorders.
* **Stress and disease:** HSC homeostasis is sensitive to various stressors, including infection, inflammation, and chemotherapy. These stressors can impact HSC function and lead to hematopoietic dysfunction.
* **Genetic mutations:** Mutations in genes involved in HSC homeostasis can cause blood disorders, such as leukemia and myelodysplastic syndromes.
**Implications of HSC Homeostasis:**
* **Blood cell production:** HSCs are essential for the continuous production of all blood cell types, ensuring proper oxygen transport, immune function, and blood clotting.
* **Disease treatment:** Understanding HSC homeostasis is crucial for developing therapies for blood disorders, such as leukemia and anemia.
* **Regenerative medicine:** HSCs have the potential to be used in regenerative medicine to treat a variety of diseases, including tissue injury and genetic disorders.'
"
Protein | Definition | Taxonomy |
---|---|---|
Ubiquitin carboxyl-terminal hydrolase BAP1 | A ubiquitin carboxyl-terminal hydrolase BAP1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q92560] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
5-(1,3-benzodioxol-5-yl)-N-(2-furanylmethyl)-7-(trifluoromethyl)-2-pyrazolo[1,5-a]pyrimidinecarboxamide | pyrazolopyrimidine | ||
N-[2-(4-acetyl-1-piperazinyl)phenyl]-2-(5-methyl-2-propan-2-ylphenoxy)acetamide | piperazines | ||
4-[[2-[(6-methyl-4-oxo-1H-pyrimidin-2-yl)thio]-1-oxoethyl]amino]benzoic acid ethyl ester | amidobenzoic acid |